United Therapeutics Company – Particular Name

Operator

Good afternoon, and welcome to the United Therapeutics Company Section 3 TETON-2 Outcomes Convention Name. My title is Drew, and I shall be your convention operator as we speak. [Operator Instructions] Please notice that this name is being recorded. I’d now like to show the webcast over to Harry Silvers, Investor Relations Supervisor at United Therapeutics.

Harrison Silvers
Supervisor of Investor Relations

Thanks, Drew. Good day, everybody. It’s my pleasure to welcome you to the United Therapeutics Company Section 3 TETON-2 outcomes convention name.

Remarks as we speak will embody forward-looking statements representing our expectations or beliefs relating to future occasions. These statements contain dangers and uncertainties that will trigger precise outcomes to vary materially. Our newest SEC filings, together with Kinds 10-Ok and 10-Q, comprise extra data on these dangers and uncertainties. We assume no obligation to replace forward-looking statements.

At this time’s remarks might talk about the progress and outcomes of scientific trials or different developments with respect to our merchandise. These remarks are meant solely to coach buyers and aren’t meant to function the idea for medical decision-making or to counsel that any merchandise are secure and efficient for any unapproved or investigational makes use of. Full prescribing data for the merchandise is obtainable on our web site.

Accompanying me on as we speak’s name are Dr. Steve Nathan, Schar Chair of the Superior